SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal informs about disclosure

23 Feb 2024 Evaluate
Hikal has informed that the Hon’ble High Court of Bombay, vide its order dated February 22, 2024, has disposed of the writ petition, filed by the Company challenging the jurisdiction of the principal bench of NGT, as not maintainable and granted liberty to the Company to seek remedies as available under law. The order of Hon’ble Bombay High Court shall operate on the expiry of a period of 4 weeks from February 22, 2024. The Hon’ble High Court has further extended the interim relief granted to the Company under its order dated March 24, 2023 for a period of 4 weeks from February 22, 2024, to enable the Company to invoke appropriate remedy.

The above information is a part of company’s filings submitted to BSE.

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×